Clinical trial
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
NCT03851068 is registered in ClinicalTrials.gov with Foldax, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Feasibility Study for the Foldax Tria Aortic Heart Valve
- Lead sponsor
- Foldax, Inc
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 18, 2019
- Completion date
- December 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.